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The relationship between the use of immunosuppressants in solid-organ transplant patients and oral tissue abnormalities has
been recognized. The objective of this study was to determine the state of oral tissue integrity in renal, heart, and liver transplant
patients who are on continuous medical and dental control. Forty patients of both sexes were clinically evaluated at the Clinical
Hospital of the University of Chile to identify pathologies of oral mucosa, gingival enlargement (GE), decayed, missing, ﬁlled teeth
(DMFT) index, and salivary ﬂow. The average age of the transplant subjects was 49.4 years, and the age range was 19 to 69 years.
Most subjects maintained a good level of oral hygiene, and the rate mean of DMFT was 14.7. The degree of involvement of the oral
mucosa and GE was low (10%). Unlike other studies, the frequency of oral mucosal diseases and GE was low despite the fact that
these patients were immunosuppressed. Care and continuous monitoring seem to be of vital importance in maintaining the oral
health of transplant patients.
1.Introduction
Organ transplantation is a widely used treatment for the
functional failure of an organ. The life expectancies of
patients who have received heart, lung, kidney, liver, or bone
marrow transplants have improved substantially in recent
years [1], partly due to improvements in surgical techniques
and the immunosuppressive drug therapies used to prevent
transplant rejection [1]. From 1992 to 2009 in Chile, there
have been a total of 4570 solid-organ transplants, including
3494 kidney transplants, 768 liver transplants, and 198 heart
transplants [2].
Immunosuppressive therapy has a number of short- and
long-term eﬀects including infection, increased cardiovascu-
lar risk, and neoplasm that may threaten the patient’s life
[3,4].Thistreatmentdepressesthecellularimmuneresponse
[5]. Cyclosporin A, the most widely used immunosup-
pressive drug, acts selectively on T-cell-mediated immune
responses [1]. Clinically, this eﬀect means a high risk of oral
infections and associated complications. In patients who are
treated with immunosuppressants, oral pathogens can cause
local destruction and opportunistic infections due to the
inability of the immune system to suppress and destroy
pathogens. Lesions inthe oral cavitycoulddevelop as aresult
of these side eﬀects or drug interactions [5].
At the periodontal level, gingival enlargement (GE) asso-
ciated with immunosuppressive therapy with cyclosporin A
usually appears within the ﬁrst 12 months of use [6], and
the risk is increased with the concomitant use of calcium
channel blockers and poor oral hygiene [7–10]. Studies have2 Journal of Transplantation
reported the presence of GE in 7–74.1% of renal transplant
patients [11–15], and 22% of liver transplant patients are
reportedly aﬀected [4]. In a study that evaluated patients
with heart, liver, and kidney transplants, 43% presented GE,
andthemajorinﬂuencingfactorwasthebloodconcentration
of cyclosporin A, followed by plaque and gingivitis levels
[10].
Studiesofrenaltransplantpatientsshowalowpercentage
of lesions in the oral mucosa, with the most common lesions
beingcandidiasis[11–17],herpessimplexinfections[15,17],
hairy leukoplakia [13–15], ﬁssured tongue [12], and lip
cancer[15].Inlivertransplantpatients,ﬁssuredtongueisthe
most prevalent oral mucosa injury [4], although oral ulcers
[18] and xerostomia [4] have also been observed. In heart
transplantpatients,increasedfrequenciesofcandidiasis[16],
herpes simplex virus infection [19], and oral ulcers [20, 21]
were observed in the oral cavities of patients.
The purpose of this study was to evaluate the status
of oral tissues in patients who received heart, liver, and
kidney transplants at the Clinical Hospital of the University
of Chile Jos´ eJ o a q u ´ ın Aguirre between 2008 and 2009 by
determining the history of caries, the level of oral hygiene,
and the presence of GE and oral mucosal lesions. Salivary
ﬂow and xerostomia status were also assessed.
2.MaterialsandMethods
A descriptive cross-sectional study was conducted from
2008 to 2009 with a sample of 22 males and 18 females
(40 patients) who had received solid-organ transplants at
the Hospital of the University of Chile, including heart (8
patients), liver (17 patients), and renal (14 patients) trans-
plants and one combined heart and kidney transplant. The
study was approved by the institutional Ethics Committee,
and all patients expressed their willingness to participate
through an informed consent form. We included patients
who were 18 years of age or older, were transplant recipients,
and had undergone transplantation at least 6 months prior
to the study. Exclusion criteria included patients who refused
to participate in the study, patients with reduced or altered
cognitive function, and patients whose transplants were not
functional and required new transplants.
Data from each patient were collected following a set
protocol, which included demographic data, general medical
history, oral and dental history, intraoral clinical examina-
tion,andrecordofsalivaryﬂowandconditionofxerostomia.
In the general medical history, the type of transplant, the
time elapsed since transplantation, and current medications
were recorded. For the oral and dental history, patients were
asked whether they had received pretransplant dental eval-
uations or used prosthetic devices. Patients were also asked
about their oral hygiene habits, including the frequency of
brushing and the use of mouthwash and dental ﬂoss.
All patients were examined in a dental chair under
direct light at the Dento Maxillo Facial Department of the
hospital. The instruments used were a no. 5 mouth mirror,
gloves, and a mask, and a photographic record was taken
for each patient. Clinical examination was performed by an
operatorwhowaspreviouslytrainedforeachoftheevaluated
variables and a required kappa value greater than 0.6. The
history of cavities was deﬁned through the DMFT index,
which was measured by visual inspection. At the periodontal
level, the level of oral hygiene was assessed through the
Simpliﬁed Oral Hygiene Index of Greene and Vermillion
[22], and GE was deﬁned as an overgrowth of the gum with
a lobed granular appearance that covered at least one-third
of the buccal crown. Both assessments were made by visual
inspection. At the level of the oral mucosa, we assessed the
presence of oral mucosal lesions associated with solid-organ
transplantation [1]: recurrent labial herpes simplex, oral
candidiasis, oral ulcers, hairy leukoplakia, ﬁssured tongue,
and lichenoid reaction. Finally, salivary ﬂow was measured
through the oral salivary ﬂow rate test of Schirmer [23].
For all variables, we performed descriptive analyses
through tables, graphs, and numerical representations of
measures of central tendency and dispersion using Stata
11.0 for Windows. The chi-square test was used to compare
nominal variables between groups of transplant patients.
The Kruskal-Wallis test was used for ordinal variables, and
ANOVA was used for quantitative variables. For all tests,
av a l u eo fP<0.05 was considered signiﬁcant, with a
conﬁdence interval of 95%.
3. Results
Thesampleconsistedof40peoplewithanaverageageof49.4
years and an age range of 19 to 69 years. The age diﬀerence
between men and women was not signiﬁcantly diﬀerent.
The average age was 42 ± 16.3 years for heart transplant
patients, 40 ± 11.4 years for renal transplant patients, and
58.2 ±7.7 years for liver transplant patients.
Most of the patients received single-organ transplants.
The elapsed time since transplantation was highly variable
and ranged from 6 to 192 months (16 years), with an average
time of 57.8 months. Renal transplant patients had the
longest period since transplantation, with an average of 84.2
months. No relationship was found between patient age and
time since transplantation (Table 1).
One 67-year-old patient received a heart-kidney double
transplant, with a 51-month survival for both transplants.
Five patients were excluded because their time since trans-
plantationwaslessthan6months.Womenhadloweraverage
times since transplantation than men.
Most of the patients took between three and ﬁve
drugs, mainly immunosuppressants, and cyclosporin and
corticosteroids were the most common drugs. Another type
of commonly used drug was antihypertensives (Table 2).
There was no diﬀerence between men and women in the
number of drugs taken.
Mostpatientsreportedatoothbrushingfrequencyoftwo
to three times daily. However, a signiﬁcant proportion of
women reported a frequency of four times per day, which
was signiﬁcantly higher than the frequency reported by the
men. This high reported frequency of brushing is consistent
with the oral hygiene index, which was low for most patients.
Thus, 85% of patients had an index score lower than 1.
Notably, 16 patients had a score of 0, indicating a very low
level of bacterial plaque.Journal of Transplantation 3
Table 1: Clinical and demographic characteristics of the study sample.
Total Men Women P
40 22 18
Age (years) 49.4 ± 13.95 0 .5 ±12.84 8 .1 ±15.3
Type of transplant
Liver 17 8 9 NS
Renal 14 10 4 NS
Cardiac 8 3 5 NS
Cardiac-renal 1 1 0
Time since transplant (months) 57.8 ± 49 67 ± 57.6 46.4 ±35.9
Number of drugs consumed
0 – 2 220 N S
3 – 5 3 71 91 8 N S
6 o r m o r e 110 N S
T o t a l 4 02 21 8 N S
Frequency of brushing
0 - 1 t i m e s p e r d a y 110 N S
2-3 times per day 31 20 11 NS
4 t i m e s p e r d a y 817 P<0.01
Oral Hygiene Index
01 6 1 0 6 N S
1 1 881 0 N S
2 642 N S
3 000
Damage from caries (DMFT) 14.7 ±6.71 5 .4 ±6.41 4 .1 ±7.1N S
Gingival enlargement 4 3 1 NS
Oral mucosa lesions
Fissured tongue 7 4 3 NS
Candidiasis 3 3 0 NS
H e r p e s s i m p l e x 101 N S
C a n k e r s o r e s 110 N S
Other 11 7 4 NS
No lesion 21 10 11 NS
H y p o s a l i v a t i o n 312 N S
Table 2: Main drugs consumed.
Drugs N◦ %
Antihypertensives 32 80
Cyclosporin 31 77,5
Corticosteroids 23 57,5
Mycophenolate 16 40
Insulin 7 17,5
Tacrolimus 7 17,5
The history of damage from caries (DMFT) showed an
average of 14.7 teeth aﬀected by caries, either from carious
cavitation or loss by decay. There was no gender diﬀerence in
the level of damage from caries.
Only four patients had GE, three of whom were
men. Most patients exhibited good periodontal protection
(Figures 1, 2,a n d3).
Oral mucosal lesions were rare. There was no diﬀerence
in the frequency between males and females for each oral
lesion (Table 1). The majority of oral mucosal lesions in-
volved ﬁssured tongue, a relatively common condition in the
general population. Candidiasis was observed in three male
patients. No cases of hairy leukoplakia, a condition usually
described in immunosuppressed patients, were observed.
A descriptive analysis was conducted for oral mucosal
lesions associated with immunosuppression and its relation
to the time elapsed since transplantation. On one hand, in
the three cases of candidiasis, the time of transplantation
was under ﬁve years (mean 35,3 months). On the other
hand, AG cases presented a wide time range elapsed since4 Journal of Transplantation
Figure 1: Gingival enlargement can be seen covering part of the
coronal portion along with the absence of plaque or calculus
(25-year-old male heart transplant patient who had cyclosporin
treatment only).
Figure 2: Gingival enlargement can be seen with signs of
inﬂammation in a patient with plaque and calculus (31-year-old
female renal transplant patient who was treated with cyclosporin,
mycophenolate, and corticosteroids).
Figure 3: Gingival enlargement with signs of inﬂammation and
presence of dental calculus in the lower third of the dental crowns
(49-year-old male kidney transplant patient who was treated with
cyclosporin).
transplantation (from 16 to 120 months), and no relation
was observed between these variables. The same analysis
was conducted for drugs intake and oral lesions. The results
showed no relation between development of oral pathology
with type and number of immunosuppressive medications.
Salivary ﬂow was preserved for the majority of patients.
Only three patients became hyposalivatory.
4. Discussion
This study aimed to assess the state of oral tissues in patients
who received heart, liver, and kidney transplants at the
Hospital of the University of Chile Jos´ e Joaquin Aguirre
between 2008 and 2009 by determining the history of caries,
the level of oral hygiene, and the presence of GE and oral
mucosal lesions.
Patientsinthesamplewereadults,withnoagediﬀerences
between men and women. At the time of the study, kidney
transplant patients had the lowest average age, and liver
transplant patients had the highest average age. This age
range is similar to the ranges reported in previous studies,
which also show that renal transplant patients generally have
a lower average age compared to liver and cardiac transplant
patients (Table 3).
The results of this study show that the frequency of
oral mucosal pathologies was lower than that expected for
this type of patient. The immunosuppressed condition is
associated with the presence of several diseases, including
candidiasis, hairy leukoplakia, and herpes virus infections,
whicharepromotedbythereducedexpressionofcellularand
humoral eﬀector mechanisms. The low occurrence in this
study may be explained by methodological reasons related to
sampleselection.Transplantationmusthaveoccurredatleast
6 months prior for the patient to be included in the study.
If the inclusion criteria had required a minimum of 2 years
since receiving the transplant, then perhaps a larger number
of oral mucosal lesions would have been observed, mainly
due to noninfectious diseases. However, the time variable
should not be relevant to the discovery of infectious diseases.
Alternatively, it can be assumed that the rigorous and
close clinical monitoring of patients promotes general health
conditions that tends to keep opportunistic infections com-
monly associated with immunosuppression under control.
Others variables like nutritional status [24], hygiene habits
[25], denture wearers, hyposialia, or the psychological status
[26] can modulate the expression of infectious pathology
in immunosuppressed patients. For example, some studies
show that patients who receive hematopoietic stem cell
transplantation have greater diﬃculty with oral hygiene
habits than no transplanted patients [27], which is probably
due to their xerostomic condition.
Maybeoralhygienehabitsarethemostimportant topre-
vent oral infectious diseases in immunosuppressed patients.
Goldman suggests that all transplantation patients and their
caregivers should be educated regarding the importance of
maintaining good oral and dental hygiene to reduce the
risk for oral and dental infections. The maintenance of
safe oral hygiene after transplantation can minimize the
severity of infections and facilitate healing of mucositis.Journal of Transplantation 5
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Consultation with physicians or transplant coordinators,
frequent recall and oral prophylaxis, and daily antibacterial
mouth rinses, all indicating dental care, consideration of
antibiotic prophylaxis for invasive procedures, and careful
screening for head and neck cancers, are suggested for dental
treatment and care of the stable posttransplant patient [25].
We think that in our study the patients are being taken care
of under these recommendations; therefore, they have good
oral tissues conditions and a lower oral diseases frequency.
A close clinical monitoring can reduce the immuno-
suppression eﬀect on the development of infectious disease
of oral mucosal through the healthy behavior promotion
like good feeding, physical exercise, oral hygiene, or better
psychological attitude toward health care.
Candidiasis is an opportunistic infection that is common
in immunosuppressed patients and is more common in
transplant patients than that in nontransplant patients [16].
Several studies have reported an average rate of candidiasis
higher than 15% for renal transplant patients. In our study, a
lower percentage of patients (7.5%) had clinical candidiasis
infections. This result agrees with the results obtained by
Dongari-Bagtzoglouetal.[16]inastudyofrenalandcardiac
transplant patients. This low occurrence of candidiasis is
not explained by the use of antifungal treatment because
only one patient received this treatment. However, we must
keep in mind that candidiasis do not only depends on
systemic condition. Local factors are also important mainly
the salivary ﬂow. Our patients do not have a signiﬁcant
hyposialia, which is a risk factor for the fungal infection [28].
Therefore, this ﬁnding could explain the lower percentage
of candidiasis than that in other studies. Regrettably, these
do not inform about salivary, ﬂow and comparisons are not
possible.
In our study, two cases of candidiasis were found in liver
transplant patients, and one case was found in a patient who
hadadoublecardiac-renaltransplant.Theagesofthesethree
patients were above 65 years, which is well above the average
age for the study sample. Patient age could explain the fact
that, in a context of noninfectious compromise of the oral
cavity, three patients had this infection. Advanced age is a
described risk factor for developing candidiasis [29], and,
therefore, these cases might be explained by this risk factor.
The relationship between the consumption of cyclosporin
and candidiasis is known; however, two of the reported
cases were not being treated with cyclosporine, but with
other immunosuppressive drugs: tacrolimus in one case and
mycophenolate in the other, so the risk is the same because
of the higher dosages of mycophenolate and tacrolimus
correlated with symptomatic mucosal candidiasis [30].
GE has been described as a pathology produced by the
consumption of some drugs, including phenytoin sodium
and cyclosporin [31]. Our data show that GE was not a
signiﬁcant ﬁnding in our study, as only four cases were
recorded. Other studies show higher frequencies of GE;
percentages exceeding 70% of renal transplant patients have
been reported [13] .T h el i t e r a t u r eh a sr e p o r t e dt h a tG E
depends on the eﬀects of the drugs used and that the level of
bacterialplaquealsoplaysasigniﬁcantroleinthehyperplasia
suﬀered by periodontal tissues. Our ﬁndings support this
observation because subjects who were enrolled in the study
showed good oral hygiene with low plaque indexes.
Other diseases of the oral mucosa that are usually
observed in transplant patients are hairy leukoplakia and
herpes virus infections. In our study, no case of hairy
leukoplakia was recorded, and there was only one case of
recurrent labial herpes. Other studies have shown frequen-
cies in the range of 3–12% for leukoplakia and 2–7% for
herpesinfection.Itislikelythatthesmallersizeofoursample
was a factor in the very low frequency of these conditions.
However, our ﬁndings are consistent with other studies in
that both of these pathological conditions are less prevalent
than candidiasis and GE in our sample.
Of the other oral mucosal diseases, only ﬁssured tongue
was observed frequently. Although several studies did not
report data regarding the presence of ﬁssured tongue, those
that did report data showed a percentage exceeding 35% of
the sample, which is higher than the frequency observed in
the present study. Fissured tongue is a benign disorder of
little clinical relevance and is not uncommon in a clinically
healthy population. Darwazeh and Almelaih [32] showed
a prevalence of 11.5% in normal subjects in Jordanian
population. Koay et al. [33] found a similar result in dental
outpatients in Malaysia (13.8%), and higher frequency than
25% has been described in denture wearers older patients.
Therefore, it is not possible to make a direct association
between the prevalence of this condition and the condition
of a renal, heart, or liver transplant recipient. The diﬀerence
in prevalence with the other studies may be related to
ethnicity, the criteria used to diagnose ﬁssured tongue, or the
hyposialia condition. Several reports show the relationship
between hyposialia and ﬁssured tongue [34]. Maybe the
lowest frequency of ﬁssured tongue would be explained by
the salivary ﬂow maintenance in our patients.
Hyposalivation is not a common complication in trans-
plant patients. In total, 0.6% of the subjects studied by
L´ opez-Pintor et al. [17] presented with hyposalivation. A
similar percentage was observed in our study. However,
these observed frequencies are similar to those of a healthy
population. This ﬁnding suggests that salivary ﬂow is
unaﬀected despite the many drugs that transplant patients
receive. In our sample, a signiﬁcant percentage of patients
(90%) received antihypertensives, which are associated with
hyposalivation; however, this symptom was not common in
our study.
Most of the sample population took more than three
drugs concomitantly. In total, 90% were under an immuno-
suppressionregimenwithcyclosporinandantihypertensives.
A substantial fraction took oral corticosteroids. However,
oral tissue damage was minimal despite the many drugs that
were taken. We believe that this result is due to the close
clinical supervision by professional teams in the respective
transplant units of the hospital.
While acknowledging the impact of courtesy bias or
social desirability phenomena when it comes to answering
behavioral questionnaires, the results of this study show
signiﬁcant adherence to oral hygiene care. As shown in
Table 1, almost 100% of the patients brushed their teeth
two to four times per day. This ﬁnding is consistent withJournal of Transplantation 7
clinical ﬁndings of the oral hygiene index, which showed a
vast majority of patients with a score below 1, meaning that
the dental calculus or plaque covered less than a third of the
coronal portion of the teeth.
The integrity of oral tissues for patients who participated
in this research is good and clearly better than that observed
in the general population of Chile. Oral health indicators
show severe damage as a result of caries and periodontal
disease in Chilean people [35]. Thus, the doctor-patient
relationship is thought to be essential for these patients.
Therespectivemedicalteamsmaintainclose,permanentcare
relationships and are committed to all health aspects of their
transplant patients. Additionally, the Clinical Hospital of the
University of Chile has a Dento Maxillo Facial Department
with highly trained professionals to care for transplant
candidates, in which a strict clinical protocol is followed
including instructions for maintaining good oral hygiene. In
the cases presented in this study, all patients had attended a
pretransplant evaluation.
The ﬁndings of this study suggest that despite the
vulnerability to the development of oral diseases involved in
immunosuppressioninsolid-organtransplantpatients,these
patients can exhibit appropriate maintenance of oral tissue
integrity, provided they are properly assessed, treated, and
trained for the prevention of complications arising from the
use of drugs that are known for their deleterious eﬀects on
the oral mucosa and periodontal and dental structures.
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